Global stock markets rise ahead of US jobs report

→ Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad)

In this photo provided by the New York Stock Exchange, specialist James Denaro works at his post on the trading floor, Thursday Dec. 3, 2020. U.S. stocks are inching further into record heights Thursday, as Wall Street continues to coast following its rocket ride last month powered by hopes for coming COVID-19 vaccines. (Nicole Pereira/New York Stock Exchange via AP)

BEIJING (AP) — Global stock markets and U.S. futures rose Friday ahead of the latest report on the pace of American hiring and after major oil producers agreed to increase production gradually.

Benchmarks in London, Shanghai, Paris and Hong Kong advanced while Tokyo declined. U.S. stock futures were up slightly.

Investors are looking ahead to the monthly jobs report, which analysts think will show a slight slowdown in the pace of hiring in November from the previous month’s 638,000.

Market sentiment has also been improved this week by data showing fewer Americans than expected applied for jobless benefits last week and service industries grew in November. They also were optimistic about possible progress toward a new U.S. economic aid plan.

“Expectations of a holiday pandemic relief bill are offsetting the immediate pain the coronavirus is having on the economy,” Edward Moya of Oanda said in a report. “Expectations are high for the virus lockdowns to improve in January as vaccines are produced and distributed.”

The FTSE 100 in London was up 0.8% to 6,544 and the CAC 40 in Paris added 0.4% to 5,595. The DAX in Frankfurt was down less than 0.1% at 13,243.

On Wall Street, the futures for the S&P 500 index and the Dow Jones Industrial Average were up 0.4%.

In Asia, the Shanghai Composite Index added less than 0.1% to 3,444.58 while the Nikkei 225 in Tokyo shed 0.2% to 26,751.14. The Hang Seng in Hong Kong rose 0.4% to 26,835.92.

The Kospi in Seoul gained 1.3% to 2,731.45 and Sydney's S&P-ASX 200 was 0.3% higher at 6,634.10. India's Sensex rose 0.6% to 44,887.17.

Investors hope one or more coronavirus vaccines might be available next year despite the challenges of making and distributing billions of doses that must be kept frozen.

Pfizer, which received British approval for emergency use of its vaccine, told The Wall Street Journal that testing and setting up a supply chain took longer than expected.


Also Thursday, U.S. health authorities reported a one-day record of 3,157 virus deaths.

“Before we can make new gains, there is the usual sentiment tug of war between medium-term optimism and near-term COVID-19 despair,” Stephen Innes of Axi said in a report.

Investors have been encouraged by signs Democrats and Republicans in Washington may get past their bitter partisanship to agree on an economic aid package.

House Speaker Nancy Pelosi and Senate Majority Leader Mitch McConnell spoke Thursday after Pelosi signaled a willingness to make concessions. President-elect Joe Biden urged Congress on Wednesday to pass a relief bill now, with more aid to come next year.

Oil prices edged higher after OPEC and allied countries including Russia agreed Thursday to increase oil production only gradually, starting with 500,000 barrels per day in January. They slashed output earlier to shore up prices as curbs on business depressed demand.

Benchmark U.S. crude gained 40 cents to $46.04 per barrel in electronic trading on the New York Mercantile Exchange. The contract rose 36 cents on Thursday. Brent crude, used to price international oils, was up 43 cents at $49.14 per barrel in London. It added 46 cents the previous session.

The dollar edged up to 103.99 yen from Thursday's 103.97 yen. The euro rose to $1.2167 from $1.2143.

→ Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad)

Should you invest $1,000 in Pfizer right now?

Before you consider Pfizer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pfizer wasn't on the list.

While Pfizer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Featured Articles and Offers

7 Stocks to Help You Build Off January’s Gains

7 Stocks to Help You Build Off January’s Gains

It's frequently said that as January goes, so goes the market. If that's the case, it's time for investors to put money to work in the stock market.

Search Headlines: